XML 46 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Net Income (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Sep. 27, 2014
Sep. 28, 2013
Net sales $ 217,608 [1] $ 201,040 [1] $ 645,375 [1] $ 559,724 [1]
Cost of sales 130,228 120,080 396,506 340,601
Gross profit 87,380 80,960 248,869 219,123
Selling, general and administrative expenses 36,647 34,437 109,146 98,091
Research and development expenses 7,449 6,217 22,833 17,725
Amortization of intangibles 3,154 2,747 9,451 6,249
47,250 43,401 141,430 122,065
Operating income 40,130 37,559 107,439 97,058
Interest expense 1,292 939 3,736 1,959
Impairment and equity in net loss of unconsolidated affiliate    [2]    [2]    [2] 10,678 [2]
Foreign exchange (gain) loss (101) 1,476 2,022 (1,929)
Other (income) expense, net (2,261) (1,380) (4,893) (3,543)
Income before income taxes 41,200 36,524 106,574 89,893
Income taxes 11,260 9,534 26,667 24,767
Net income $ 29,940 $ 26,990 $ 79,907 $ 65,126
Net income per share (see Note 8):        
Basic (in Dollars per share) $ 1.33 $ 1.20 $ 3.55 $ 2.92
Diluted (in Dollars per share) $ 1.32 $ 1.19 $ 3.52 $ 2.89
Weighted average shares and equivalent shares outstanding:        
Basic (in Shares) 22,536 22,428 22,536 22,274
Diluted (in Shares) 22,689 22,625 22,722 22,497
Cash dividends paid per common share (in Dollars per share) $ 0.25 $ 0.22 $ 0.69 $ 0.62
[1] Sales by country represent sales to customer or distributor locations.
[2] During the first quarter of 2013, the company recorded an impairment of its investment in Shocking Technologies. (See Note 5).